# Pancreatic Cancer Recurrence in the Netherlands

> **NCT04605237** · — · UNKNOWN · sponsor: **UMC Utrecht** · enrollment: 1750 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma
- Pancreatic Cancer
- Pancreas Cancer
- PDAC

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04605237
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01-01
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 1750 (ESTIMATED)
- **Last updated:** 2023-02-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04605237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04605237, "Pancreatic Cancer Recurrence in the Netherlands". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04605237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*